Erratum to: Randomized open label phase III trial of CEOP/IMVP-Dexa alternating chemotherapy and filgrastim versus CEOP/IMVP-Dexa alternating chemotherapy for aggressive non-Hodgkin’s lymphoma (NHL). A multicenter trial by the Austrian Working Group For Medical Tumor Therapy
Titel:
Erratum to: Randomized open label phase III trial of CEOP/IMVP-Dexa alternating chemotherapy and filgrastim versus CEOP/IMVP-Dexa alternating chemotherapy for aggressive non-Hodgkin’s lymphoma (NHL). A multicenter trial by the Austrian Working Group For Medical Tumor Therapy
Auteur:
Fridrik, M. A. Greil, R. Hausmaninger, H. Krieger, O. Oppitz, P. Stöger, M. Klocker, J. Neubauer, M. Helm, W. Pont, J. Fazeny, B. Hudec, M. Simonitsch, I. Radaszkiewicz, T.